On May 11, 2026, six insiders at Artiva Biotherapeutics, Inc. (ARTV) executed significant share purchases, collectively acquiring approximately $450 million worth of stock. The transactions were made at a price of $11.52 per share.
Among the notable buyers were Capital Healthcare Fund Lp Ra, Capital Management, L.P. Ra, Peter Kolchinsky, Rajeev M. Shah, Capital Nexus Fund, L.P. Ra, and Capital Nexus Fund Iii, L.P. Ra, each acquiring 6,510,416 shares. These individuals hold significant positions within the company, including directorships and 10% ownership stakes.
This cluster buying, where multiple insiders purchase shares concurrently, is often regarded as a strong bullish signal by market observers, suggesting a positive outlook on the company's future prospects.